Can a new stent graft reinforce a weakened aorta and prevent rupture?
NCT ID NCT07754240
First seen Aug 10, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This trial is testing a new stent graft system designed to treat abdominal aortic aneurysms—a bulging, weakened area in the main artery. The device is placed inside the aorta to reinforce the wall and prevent rupture. The study includes adults with infrarenal abdominal aortic aneurysms who are suitable for endovascular repair. Researchers are evaluating how safe the device is in the first 30 days and how well it works over 12 months, looking at factors like aneurysm growth, device movement, and the need for further procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ankura II Abdominal Aortic Stent Graft System (a device implanted to reinforce the weakened aorta wall)
- What this could lead to
- If successful, this could offer a safer, more effective minimally invasive option for repairing abdominal aortic aneurysms, potentially reducing complications and improving long-term outcomes.
- What could go wrong
- This is an early-stage study with a small number of patients, so results may not apply to everyone. Risks include bleeding, infection, device migration, or the aneurysm leaking or rupturing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTIC ANEURYSMS (AAA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MBAL Heart and Brain EAD
Pleven, Bulgaria
More trials for these conditions
Other studies related to the condition(s) this trial covers.